(Q37101300)

18 August 2017

1 reference

title

Combination therapies in multiple sclerosis (English)

1 reference

18 August 2017

0 references

1

Ralf Gold

1 reference

18 August 2017

publication date

1 March 2008

1 reference

18 August 2017

1 reference

18 August 2017

volume

255 Suppl 1

1 reference

18 August 2017

page(s)

51-60

1 reference

https://scigraph.springernature.com/pub.10.1007/s00415-008-1008-2

18 August 2017

exact match

0 references

cites work

Mechanism of action of mitoxantrone

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00415-008-1008-2

Combination therapy with glatiramer acetate (copolymer-1) and a type I interferon (IFN-alpha) does not improve experimental autoimmune encephalomyelitis

21 January 2018

1 reference

12 December 2020

Atorvastatin and glatiramer acetate: new hope in MS?

1 reference

12 December 2020

Sequential maintenance treatment with glatiramer acetate after mitoxantrone is safe and can limit exposure to immunosuppression in very active, relapsing remitting multiple sclerosis.

1 reference

12 December 2020

Mitoxantrone in progressive multiple sclerosis: a placebo-controlled, double-blind, randomised, multicentre trial

1 reference

12 December 2020

Mechanisms of mitoxantrone in multiple sclerosis--what is known?

1 reference

12 December 2020

Lovastatin treatment decreases mononuclear cell infiltration into the CNS of Lewis rats with experimental allergic encephalomyelitis

1 reference

12 December 2020

Heterogeneity of multiple sclerosis lesions: implications for the pathogenesis of demyelination

1 reference

12 December 2020

The HMG-CoA reductase inhibitor, atorvastatin, promotes a Th2 bias and reverses paralysis in central nervous system autoimmune disease

1 reference

12 December 2020

Natalizumab plus interferon beta-1a for relapsing multiple sclerosis

1 reference

12 December 2020

Immunomodulatory synergy by combination of atorvastatin and glatiramer acetate in treatment of CNS autoimmunity

1 reference

12 December 2020

Azathioprine and interferon beta(1a) in relapsing-remitting multiple sclerosis patients: increasing efficacy of combined treatment

1 reference

12 December 2020

Multiple sclerosis: Mitoxantrone promotes differential effects on immunocompetent cells in vitro

1 reference

12 December 2020

Additive effect of the combination of glatiramer acetate and minocycline in a model of MS.

1 reference

12 December 2020

Treatment of rheumatoid arthritis.

1 reference

12 December 2020

Optimization of the safety and efficacy of interferon beta 1b and azathioprine combination therapy in multiple sclerosis

1 reference

12 December 2020

Suppression of experimental allergic encephalomyelitis by mitoxantrone.

1 reference

12 December 2020

Mitoxantrone immunotherapy in multiple sclerosis

1 reference

12 December 2020

Statins reduce human blood-brain barrier permeability and restrict leukocyte migration: relevance to multiple sclerosis.

1 reference

12 December 2020

Glatiramer acetate: mechanisms of action in multiple sclerosis

1 reference

12 December 2020

Immunomodulatory effects of 3-hydroxy-3-methylglutaryl coenzyme-A reductase inhibitors, potential therapy for relapsing remitting multiple sclerosis

1 reference

12 December 2020

Minocycline reduces gadolinium-enhancing magnetic resonance imaging lesions in multiple sclerosis.

1 reference

12 December 2020

Therapeutic effect of mitoxantrone combined with methylprednisolone in multiple sclerosis: a randomised multicentre study of active disease using MRI and clinical criteria

1 reference

12 December 2020

Cholesterol-lowering statins possess anti-inflammatory activity that might be useful for treatment of MS

1 reference

12 December 2020

Understanding pathogenesis and therapy of multiple sclerosis via animal models: 70 years of merits and culprits in experimental autoimmune encephalomyelitis research.

1 reference

12 December 2020

Effect of combined IFNbeta-1a and glatiramer acetate therapy on GA-specific T-cell responses in multiple sclerosis

1 reference

12 December 2020

Different effects of simvastatin and interferon beta on the proteolytic activity of matrix metalloproteinases

1 reference

12 December 2020

A randomized, placebo-controlled trial of natalizumab for relapsing multiple sclerosis

1 reference

12 December 2020

A comparison of the mechanisms of action of interferon beta and glatiramer acetate in the treatment of multiple sclerosis

1 reference

12 December 2020

Statins as immunomodulators: comparison with interferon-beta 1b in MS.

1 reference

12 December 2020

The gelatinase inhibitory activity of tetracyclines and chemically modified tetracycline analogues as measured by a novel microtiter assay for inhibitors.

1 reference

12 December 2020

Interferon beta in the treatment of multiple sclerosis: mechanisms of action

1 reference

12 December 2020

[Escalating immunomodulatory therapy of multiple sclerosis. Update (September 2006)]

1 reference

12 December 2020

Azathioprine in dermatology: the past, the present, and the future

1 reference

12 December 2020

Targeting leukocyte MMPs and transmigration: minocycline as a potential therapy for multiple sclerosis

1 reference

12 December 2020

Tetracyclines inhibit tissue collagenase activity. A new mechanism in the treatment of periodontal disease

1 reference

12 December 2020

Mitoxantrone induces cell death in peripheral blood leucocytes of multiple sclerosis patients

1 reference

12 December 2020

10.1007/S00415-008-1008-2

Identifiers

DOI

1 reference

18 August 2017

1 reference